NCT00476554 2021-12-22
A Randomized Phase II Study of Oral Sapacitabine in Patients With Advanced Cutaneous T-cell Lymphoma
Cyclacel Pharmaceuticals, Inc.
Phase 2 Terminated
Clinical Trials
3 trialsNCT00885963 2021-12-22
A Study of Oral Sapacitabine in Patients With Previously Treated Non-Small Cell Lung Cancer
Cyclacel Pharmaceuticals, Inc.
Phase 2 Terminated
NCT01253460 2019-09-06
Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)
M.D. Anderson Cancer Center
Phase 2 Terminated